JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Mar 18, 2026

Total Value: $555M (100.0% shares, 0.0% debt)

Holdings (17)

PTGX Protagonist Therapeutics Inc. 38.5%

Value $214M Shares 2,449,183 Est. Cost $42.63 Unrealized +92.0%

NBTX Nanobiotix S.A. 23.4%

Value $130M Shares 5,623,816 Est. Cost $7.53 Unrealized —

RAPP Rapport Therapeutics, Inc. 9.8%

Value $54.14M Shares 1,784,517 Est. Cost $23.15 Unrealized +19.5%

MGTX MeiraGTx Holdings plc 9.5%

Value $52.8M Shares 6,641,064 Est. Cost $9.84 Unrealized -15.5%

CVRX CVRx, Inc. 5.1%

Value $28.58M Shares 4,024,861 Est. Cost $19.85 Unrealized -54.0%

CTNM Contineum Therapeutics Inc. 4.1%

Value $22.62M Shares 1,979,173 Est. Cost $16.10 Unrealized -29.2%

LEGN Legend Biotech Corporation 3.2%

Value $17.71M Shares 814,586 Est. Cost $50.56 Unrealized —

XNCR Xencor, Inc. 2.1%

Value $11.45M Shares 748,062 Est. Cost $37.91 Unrealized -60.6%

PRCT Procept BioRobotics Corporation 2.0%

Value $11.26M Shares 357,939 Est. Cost $38.38 Unrealized -13.6%

FATE Fate Therapeutics, Inc. 0.6%

Value $3.32M Shares 3,379,064 Est. Cost $78.44 Unrealized -98.5%

NMRA Neumora Therapeutics, Inc. 0.6%

Value $3.311M Shares 1,849,445 Est. Cost $12.57 Unrealized -82.6%

— Rallybio Corporation 0.4%

Value $2.495M Shares 3,636,363 Est. Cost $1.34 Unrealized —

LYEL Lyell Immunopharma, Inc. 0.3%

Value $1.689M Shares 54,887 Est. Cost $11.42 Unrealized +96.0%

VOR Vor Biopharma, Inc. 0.1%

Value $703K Shares 53,732 Est. Cost $18.62 Unrealized 0.0%

NNOX Nano-X Imaging Ltd. 0.1%

Value $445K Shares 158,852 Est. Cost $15.61 Unrealized -77.0%

LAB Standard BioTools, Inc. 0.1%

Value $399K Shares 311,967 Est. Cost $2.41 Unrealized -44.4%

ACET Adicet Bio, Inc. 0.0%

Value $192K Shares 22,779 Est. Cost $11.05 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PTGX	Protagonist Therapeutics Inc.	2,449,183	$214M	38.5%	$42.63	+92.0%	COM	74366E102
NBTX	Nanobiotix S.A.	5,623,816	$130M	23.4%	$7.53	—	SPONSORED ADS	63009J107
RAPP	Rapport Therapeutics, Inc.	1,784,517	$54.14M	9.8%	$23.15	+19.5%	COM	75383L102
MGTX	MeiraGTx Holdings plc	6,641,064	$52.8M	9.5%	$9.84	-15.5%	COM	G59665102
CVRX	CVRx, Inc.	4,024,861	$28.58M	5.1%	$19.85	-54.0%	COM	126638105
CTNM	Contineum Therapeutics Inc.	1,979,173	$22.62M	4.1%	$16.10	-29.2%	CL A	21217B100
LEGN	Legend Biotech Corporation	814,586	$17.71M	3.2%	$50.56	—	SPONSORED ADS	52490G102
XNCR	Xencor, Inc.	748,062	$11.45M	2.1%	$37.91	-60.6%	COM	98401F105
PRCT	Procept BioRobotics Corporation	357,939	$11.26M	2.0%	$38.38	-13.6%	COM	74276L105
FATE	Fate Therapeutics, Inc.	3,379,064	$3.32M	0.6%	$78.44	-98.5%	COM	31189P102
NMRA	Neumora Therapeutics, Inc.	1,849,445	$3.311M	0.6%	$12.57	-82.6%	COM	640979100
—	Rallybio Corporation	3,636,363	$2.495M	0.4%	$1.34	—	COM	75120L100
LYEL	Lyell Immunopharma, Inc.	54,887	$1.689M	0.3%	$11.42	+96.0%	COM NEW	55083R203
VOR	Vor Biopharma, Inc.	53,732	$703K	0.1%	$18.62	0.0%	COM NEW	929033207
NNOX	Nano-X Imaging Ltd.	158,852	$445K	0.1%	$15.61	-77.0%	ORD SHS	M70700105
LAB	Standard BioTools, Inc.	311,967	$399K	0.1%	$2.41	-44.4%	COM	34385P108
ACET	Adicet Bio, Inc.	22,779	$192K	0.0%	$11.05	0.0%	COM NEW	007002207